ARCHIVES

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

NCI Program Develops Bioinformatics Tool To Design Cancer Drugs

September 13, 2002

Congressional Appropriations Committee Leaders Blast White Plans To Slash NIH FY 1987 Budget

February 20, 1987

BMS, Exelixis To Collaborate On Drug Development.

July 27, 2001

In Brief: MB Withdraws From Fight Over Funding New Constructions, Tosses The Ball To Ted Cooper

January 9, 1976

FDA Committee Approves NDA for Mitxantrone

March 21, 1986

Congress Funds NIH Through Fiscal Year, Re-Opening Agency With 5.7% Increase

January 12, 1996